Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New YorkInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain
05-Feb-2026
Download PDF
Strides Pharma
Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New YorkInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain